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It has been suggested that prenatal exposure to some organochlorine compounds (OCs) may adversely affect thyroid function and may, therefore, impair
neurodevelopment. The main aim of this study was to examine the relationship of cord serum levels of 1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane
(4,40-DDT), 1,1-dichloro-2,2-bis(4-chlorophenyl)ethylene (4,40-DDE), b-hexachlorocyclohexane (b-HCH), hexachlorobenzene (HCB), four individual
polychlorobiphenyl (PCB) congeners (118, 138, 153, and 180), and their sum, with neonatal thyroid stimulating hormone (TSH) levels in blood samples
in a mother–infant cohort in Valencia, Spain. This study included 453 infants born between 2004 and 2006. We measured OC concentrations in umbilical
cord serum and TSH in blood of newborns shortly after birth. Associations between neonatal TSH levels and prenatal OC exposure adjusted for
covariates were assessed using multivariate linear regression analyses. Neonatal TSH levels tended to be higher in newborns with b-HCH levels in
umbilical cord above 90th percentile (104 ng/g lipid) than in those with levels below the median (34 ng/g lipid), with an adjusted increment in neonatal
TSH levels of 21% (95% conﬁdence interval¼3, 51; P¼ 0.09). No statistically signiﬁcant association was found between the remaining OCs and TSH
at birth. Prenatal exposure to b-HCH may affect neonatal thyroid hormone status and its function in neurological development.
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Introduction
Organochlorine compounds (OCs) are synthetic chemicals
that are highly resistant to degradation, bioaccumulate in the
food chain, and may represent a human health hazard
(United Nations Environment Programme, 2007). Some
OCs, including polychlorobiphenyls (PCBs), hexachloro-
benzene (HCB), hexachlorocyclohexanes (HCHs), 1,1,1-
trichloro-2,2-bis(4-chlorophenyl)ethane (4,40-DDT), and its
main metabolite 1,1-dichloro-2,2-bis(4-chlorophenyl)ethy-
lene (4,40-DDE), have been banned or restricted for many
years in developed countries, but can still be detected in
human samples (Carrizo et al., 2006; Lopez-Espinosa et al.,
2008), largely because of dietary exposure (Herrera et al.,
1996).
Accumulation of OCs in fat tissue during the life of the
mothers may be an important source of exposure for
offspring during gestation and through breast feeding
(Waliszewski et al., 2001). These lipophilic and low-
molecular-weight substances can pass through the placenta
(Waliszewski et al., 2001; Soechitram et al., 2004) and may
interfere with development and functions of the fetus.
Epidemiological studies suggest that prenatal exposure to
PCBs (Jacobson and Jacobson, 2003) and OC pesticides
(Eskenazi et al., 2006; Ribas-Fito et al., 2007) may have
deleterious effects on neurodevelopment, which is consistent
with reports of the impact of these substances on neurobe-
havioral function in animals (Eriksson et al., 1992; Schantz
and Widholm, 2001). Thyroid hormone disruption has been
proposed as a potential mechanism of action for the
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neurodevelopment effects of some OCs (Porterﬁeld, 2000), as
thyroid hormones are important regulators of brain devel-
opment during fetal and neonatal periods (Dussault and
Ruel, 1987). Thyroid hormones are involved in neuronal
migration and proliferation (Lavado-Autric et al., 2003) and
in synaptogenesis and myelinization (Rice and Barone,
2000). Slight differences in the concentration of thyroid
hormones during pregnancy or after delivery may lead to
impaired neurocognitive development in children (Pop et al.,
2003; Alvarez-Pedrerol et al., 2007b).
Some epidemiological studies have suggested that thyroid
hormone levels may be disrupted by prenatal or perinatal
exposure to PCBs (Maervoet et al., 2007) or to other OCs
(Chevrier et al., 2008; Lopez-Espinosa et al., 2009). Various
mechanisms of action have been proposed to explain the
potential association between thyroid hormones and some
OCs, including inhibition of the function of the thyroid
stimulating hormone (TSH) receptor, competitive binding to
thyroid hormone transport proteins, or alteration of the
excretion or clearance of thyroid hormones (Boas et al.,
2006).
The aim of this study was to assess the association between
prenatal OC exposure and TSH levels at birth in a mother–
infant cohort in Valencia, Spain.
Methods
Population and Study Design
We drew the study sample from a cohort established in
Valencia as part of the INMA (Environment and Childhood)
study, a population-based cohort study in different regions of
Spain on prenatal environmental exposures in relation to
growth, development, and health from early fetal life until
childhood (Ribas-Fito et al., 2006). The Hospital Ethics
Committee of La Fe Hospital (Valencia) approved the
research protocol and all mothers gave written informed
consent before inclusion at the ﬁrst trimester of pregnancy.
Inclusion criteria were age X16 years, singleton pregnancy,
enrollment at 10–13 weeks of gestation, and delivery
scheduled at the reference hospital. Exclusion criteria were
assisted conception, chronic hypertension, and communica-
tion handicap. From February 2004 to June 2005, 840 of the
1563 eligible women were included in the study after they
signed the informed consent form (participation rate 54%).
Fifteen women were recruited in October 2003 for a pilot
study and are also included in the analysis. Among
these women, 787 were followed to delivery (28 withdrew,
5 were lost to follow-up, 6 had induced abortion, 25 had
spontaneous abortion, and 4 fetal deaths occurred). Deliv-
eries took place between May 2004 and February 2006.
Out of these 787 women, the cord blood sample at delivery
was missing in 288, the lipid analysis was missing in 24, and
neonatal TSH measurements were missing in 2 cases. Sixteen
neonates were also excluded because of maternal intake of
thyroid hormone supplements or anti-thyroid hormone
drugs, and four because neonatal TSH was measured before
2 days after delivery. Therefore, the ﬁnal study sample
comprised 453 neonates (Figure 1).
Maternal and newborn characteristics of this sample were
comparable to those of the rest of the cohort (Table 1), except
for a signiﬁcantly higher probability of missing umbilical cord
serum samples from mothers with rural residence (distant
from hospital), those with earlier miscarriages, and those
with low –birth weight. However, neonatal TSH levels did
not differ between the ﬁnal study sample and the remainder
of the enrolled cohort (P¼ 0.98).
OC Analyses and Lipid Determination
We determined the concentrations of seven individual PCB
congeners (IUPAC numbers: 28, 52, 101, 118, 138, 153, and
180), HCB, pentachlorobenzene, a-HCH, b-HCH, g-HCH,
d-HCH, 4,40-DDT, 2,40-DDT, and their metabolites 4,40-
DDE, 2,40-DDE, 4,40-DDD, 2,40-DDD in umbilical cord
serum. The laboratory analytical methods and quality
control procedures were described elsewhere (Carrizo et al.,
2006; Lopez-Espinosa et al., 2009). Brieﬂy, OC concentra-
tions were determined by gas chromatography with electron
   459 
Mothers with intake of thyroid hormone 
supplements or anti-thyroid hormone drugs 
(n=16) 
   453 Newborns included in the present study           
855 Women enrolled in the cohort 
   787 
Exclusion for fetal deaths, withdrawal, loss 
to follow-up, or induced/spontaneous 
abortions (n=68) 
   475 
No lipid analysis in umbilical cord (n=24) 
   499 
No OC analyses in umbilical cord (n=288) 
TSH sampling <2 days postpartum or 
missing (n=6)             
Figure 1. Scheme of study population, INMA-Valencia cohort, 2004–
2006. OCs: organochlorine compounds; TSH: thyroid stimulating
hormone.
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capture detection using an Agilent 6890N GC with a Micro-
ECD (Agilent Technologies, Palo Alto, CA, USA). Percent
recoveries ranged from 70% to 130% and limits of detections
(LODs) from 0.002 to 0.07 ng/ml depending on the OCs.
We determined the total cholesterol and triglycerides by
means of enzymatic methods, calculating total serum lipid
concentrations using the method of Phillips et al. (1989).
Thyroid Hormone Analysis
The laboratory analytical methods for measuring TSH at
birth were described elsewhere (Barona-Vilar et al., 2008).
Brieﬂy, neonatal TSH levels were measured in a heel-prick
blood sample spotted on ﬁlter paper, which is routinely
obtained shortly after birth for the national hypothyroidism
screening program. In preterm newborns, samples were
collected weekly in the hospital until term age, considering
the neonatal TSH value of the last gathered sample in our
analyses. TSH was measured by using time-resolved
sandwich ﬂuoroimmunoassay (AutoDELFIA, Perkin
Elmer/Wallac, Turku, Finland). LOD was 0.2mIU/l. The
inter-assay coefﬁcients of variance were 9%, 9.5%, and
6.7% for low, medium, and high concentrations of TSH,
respectively. Sensitivity and speciﬁcity were 100% and 99%,
respectively.
Other Covariates
The mothers completed two questionnaires at enrolment
during the ﬁrst (10–13 weeks) and third trimester (28–32
weeks) of pregnancy, about socio-demographic character-
istics and life style variables. The questionnaires were
administered by in-person interviews. Covariates considered
for inclusion in the models were country of birth, area of
residence, maternal age, pre-pregnancy body mass index
(BMI), pregnancy weight gain, parity, education, working
status (during the third trimester), socio-economic status,
cohabitant, smoking habit, and alcohol and caffeine
consumption. Both BMI and weight gain were classiﬁed
according to Institute of Medicine Guidelines (Abrams et al.,
2000). We applied a widely used Spanish adaptation of the
British classiﬁcation system (Domingo-Salvany et al., 2000)
to deﬁne socio-economic status according to current or most
recent occupation of the mothers or, for those without
employment outside the home, according to the husband’s
occupation. Active prenatal smoking was deﬁned as smoking
at least one cigarette per day during the third trimester.
Information on anthropometrical measurements at birth was
obtained from the hospital delivery and medical records, and
these variables were also considered as covariates. Birth
weight (g) was measured by the midwife at delivery. The
measurement was standardized for gestational age by using
the residuals method. Gestational age was established on the
basis of the date of the last menstrual period self-reported by
the mothers. However, an early ultrasound of the crown-
rump length was also available and used for gestational
dating when the difference with the last menstrual period was
equal to or greater than 7 days. This occurred in 11.9% of
the cases. Small weight for gestational age (SGA) was deﬁned
as birth weight below the 10th percentile based on growth
reference charts for gestational age by sex for a Spanish
population (Carrascosa et al., 2004).
Statistical Analysis
We determined the relationships between neonatal TSH levels
and OCs found in umbilical cord serum with detection
frequency 450% (4,40-DDT, 4,40-DDE, HCB, b-HCH,
PCBs 118, 138, 153, and 180, and sum of these four PCBs).
Neonatal TSH was log10 transformed to improve the
normality and was treated as a continuous variable. We used
one-way analysis of variance to examine covariates according
to TSH levels. The linearity of the relationship between TSH
and OC levels was evaluated by using adjusted general
additive models, comparing models with OC levels in a linear
and non-linear manner (a cubic smoothing spline with 2, 3,
and 4 degrees of freedom) by likelihood ratio test (LRT). In
general, no signiﬁcant improvement in the model (LRT
P40.05) was obtained with non-linear models. However, the
graphical examination provided some evidence of a non-
linear shape for most studied OCs, in which a different slope
for higher levels (B90th percentile) of the contaminants were
observed. Hence, OC levels were examined as a continuous
log10-transformed variable and as a categorical variable
(o50th, 50th–90th, and 490th percentiles). Parameter
estimates of the regression models were expressed as
percentage of change in neonatal TSH levels associated with
Table 1. Characteristics of the study population, INMA-Valencia
cohort, 2004–2006.
Newborn not
included (n¼ 334)
Newborn included
(n¼ 453)
Maternal variables (%)
Born in Spain 88.3 88.1
Rural residence 9.3 3.8**
Age X30 years 52.4 55.6
Pre-pregnancy
BMI426 kg/m2
23.4 24.5
Primiparous 54.2 55.6
Up to primary studies 31.1 36.0
Working in pregnancy 82.0 83.2
Smoking in pregnancy 23.9 22.2
Alcohol in pregnancy 37.6 37.6
Newborn variables (%)
Male 50.6 54.7
Birth weight o2500 g 8.4 3.8**
Gestational ageo37 weeks 7.2 5.1
SGA 13.5 9.9
Previous miscarriages 28.7 20.8**
**Po0.05 (P-value from w2 test).
BMI, body mass index; SGA, small weight for gestational age.
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a 10-fold increase in exposure (when OC levels were
considered as continuous variables) or with a change from
the percentile of reference (o50th) to the other percentiles
(50th–90th or 490th percentiles).
We used unadjusted and adjusted linear regression
analyses. Multivariate models were adjusted for variables
associated with TSH levels in bivariate analyses at a
signiﬁcance level of Pp0.20, sequentially excluding non-
signiﬁcant variables from the model after a backward
procedure, using the F test for the change in R2. In this
model, potential confounders for OCs were also retained if
the OC coefﬁcient changed by 410% when they were
dropped. Age at time of sampling was considered as a
continuous variable after log transformation, because the
adjusted R2 value was higher than when considered as a
categorical variable. The remaining covariates were categor-
ized (Table 2). OCs were examined separately to compare
results with earlier studies, replacing values below the LOD
Table 2. Characteristics of pregnant women and their newborns according to neonatal TSH levels (n¼ 453), INMA-Valencia cohort, 2004–2006.
Variables n (%) TSH (mIU/l)
GM (GSD) P
Mothers
Country of birth 0.41
Spain 399 (88.1) 1.27 (2.01)
Latin America 40 (9.2) 1.49 (1.87)
Rest of Europe 12 (2.7) 1.24 (2.45)
Residence 0.14
Urban 46 (10.1) 1.27 (2.08)
Metropolitan 225 (49.7) 1.34 (2.03)
Semi-urban 165 (36.4) 1.20 (1.95)
Rural 17 (3.8) 1.71 (1.85)
Age 0.16
o25 years 53 (11.7) 1.16 (2.04)
25–29 years 148 (32.7) 1.30 (1.86)
30–34 years 174 (38.4) 1.39 (2.04)
Z35years 78 (17.2) 1.16 (2.15)
Pre-pregnancy BMI 0.72
o19.8 kg/m2 64 (14.2) 1.36 (2.09)
19.8–26 kg/m2 277 (61.3) 1.29 (1.99)
426 kg/m2 111 (24.5) 1.25 (2.00)
Weight gain 0.33
Low (kg) 111 (24.9) 1.29 (2.20)
Normal (kg) 170 (38.1) 1.35 (1.92)
High (kg) 165 (37.0) 1.20 (1.96)
Parity 0.39
Primiparous 252 (55.6) 1.25 (1.99)
Multiparous 201 (44.4) 1.33 (2.02)
Education 0.89
Incomplete 13 (2.9) 1.33 (2.03)
Primary 150 (33.1) 1.34 (2.06)
Secondary 187 (41.3) 1.26 (1.95)
University 103 (22.7) 1.27 (2.04)
Working statusa 0.77
Housewife 65 (14.4) 1.32 (2.08)
Unemployed 98 (21.8) 1.33 (1.95)
Student 5 (1.1) 0.96 (2.72)
Employed 282 (62.7) 1.28 (1.98)
Socio-economic status 0.63
IV+V (lowest) 276 (60.9) 1.32 (2.00)
III 105 (23.2) 1.24 (2.10)
I+II (highest) 72 (15.9) 1.25 (1.88)
Cohabitant 0.53
Baby’s father 443 (97.8) 1.29 (1.99)
Others 10 (2.2) 1.48 (2.58)
Smoking 0.03**
No 350 (77.8) 1.25 (2.00)
Yes 100 (22.2) 1.48 (1.96)
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for OCs with 1/2 LOD in the continuous analysis. OC values
were lipid adjusted for the calculation of means and medians,
dividing serum residue levels by total serum lipid concentra-
tions, but considering serum lipid as a separate term in the
regression models with OCs as continuous variables. Models
excluding OC outliers (43 standard deviation (SD) from
mean) were re-run. As no major differences were found, the
results are presented with all data included. The normality
and homoscedasticity of regression residuals were also
assessed. STATA version 9 statistical software package
(Stata Corporation, College Station, TX, USA) was used
for the data analyses.
Results
Study Population
Table 2 shows characteristics of pregnant women and their
newborns according to neonatal TSH levels (n¼ 453).
Brieﬂy, mean maternal age was 30 years (range¼
16–43 yrs). Approximately 11% of the women were from
other countries. Mothers who smoked during pregnancy
(22.2%) had infants with higher TSH levels (Table 2).
The mean birth weight and length of the newborns were
3286 g (range¼ 1200–4600 g) and 50 cm (38–56 cm), respec-
tively, and the mean gestational age was 40 weeks (30–42
wks). TSH levels were higher in male newborns, newborns
with SGA, and in samples collected soon after birth (Table 2).
Finally, the median age of neonates at the time of the heel
prick was 3 days.
TSH Status in Newborns and Concentrations of OCs in
Umbilical Cord Serum
Table 3 shows the geometric means (GM), 95% conﬁdence
intervals (CI), and 50th and 90th percentiles of OC content
in umbilical cord serum (ng/g lipid) and neonatal blood TSH
levels (mIU/l).
The levels of PCBs increased with congener chlorination.
Thus, PCB 118 was found in 72%, PCB 138 in 86%, PCB
153 in 95%, and PCB 180 in 92%. GM for the sum of four
PCBs was 0.33 ng/ml (131 ng/g lipid). Among the other
OCs, 4,40-DDE was the most frequently detected in cord
samples (99.8% detected, GM¼ 0.49 ng/ml, or 197 ng/g
Table 2. Continued
Variables n (%) TSH (mIU/l)
GM (GSD) P
Alcohol intake 0.86
0 g/day 281 (62.4) 1.29 (2.02)
0–1 g/day 120 (26.7) 1.28 (1.95)
41 g/day 49 (10.9) 1.36 (2.06)
Caffeine intake 0.63
0–100mg/day 324 (72.0) 1.28 (2.01)
4100–200mg/day 97 (21.6) 1.37 (2.04)
4200mg/day 29 (6.4) 1.23 (1.83)
Newborns
Sex 0.03**
Male 248 (54.7) 1.38 (1.98)
Female 205 (45.3) 1.19 (2.02)
Low birth weight 0.20
o2500 g 17 (3.8) 1.74 (2.62)
Z2500 g 436 (96.2) 1.27 (1.98)
Prematurity 0.76
o37 weeks 23 (5.1) 1.23 (2.27)
Z37 weeks 430 (94.9) 1.29 (1.99)
SGA 0.03**
Yes 45 (9.9) 1.59 (2.13)
No 408 (90.1) 1.26 (1.98)
Time of TSH sampling 0.01**
2 days 182 (40.3) 1.44 (1.99)
3 days 163 (36.1) 1.27 (2.01)
4 days 48 (10.6) 1.07 (1.89)
Z5 days 59 (13.0) 1.11 (2.02)
**Po0.05 (P-value from ANOVA test).
BMI, body mass index; GM, geometric mean; GSD, geometric standard deviation; SGA, small weight for gestational age; TSH, thyroid stimulating
hormone.
aWorking status at third trimester.
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lipid). Finally, the median neonatal TSH was 1.4mIU/l
(range¼ 0.2–8.3mIU/l).
Association between Neonatal TSH Levels and OCs in
Umbilical Cord Serum
Table 4 shows the association between neonatal TSH levels in
blood and umbilical cord serum OC concentrations in the
unadjusted and adjusted analyses. After adjustment for
covariates, newborns with higher (490th percentile) prenatal
exposure to b-HCH had an increment in neonatal TSH
levels of 21% (95% CI¼3.0, 50.8; P¼ 0.09) in compar-
ison to babies with lower (o50th percentile) exposure to this
compound (GM¼ 0.39 ng/ml or 151 ng/g lipid versus
0.01 ng/ml or 5.9 ng/g lipid). Median b-HCH levels for the
whole population and those with levels higher than 90th
percentile were 0.08 ng/ml (34 ng/g lipid) and 0.33 ng/ml
(131 ng/g lipid), respectively.
Discussion
TSH levels tended to be higher in newborns with greater
b-HCH levels in umbilical cord than in those with levels
below the median (P¼ 0.09). No statistically signiﬁcant
association was found between the remaining OCs and
neonatal TSH.
In this study, b-HCH was detected in 78.4% of samples at
a median level of 0.08 ng/ml (34 ng/g lipid). b-HCH is an
isomer of the pesticide formulation of HCH, which was
widely used from the 1940s, but whose commercial use in
most countries has been banned or restricted for two or more
decades (Breivik et al., 1999). The strongest insecticide
properties of HCH derive from the g-isomer (lindane). Some
uses of lindane were authorized in Spain until recently (PNA
Convenio Estocolmo y Reglamento 850/2004, 2007).
Lindane may be transformed into other isomers such as
b-HCH (Walker et al., 1999), which has high physical and
metabolic stability due the positions of its chlorine atoms,
explaining its environmental and biological persistence
(Willet et al., 1998).
Authors have suggested that b-HCH may cause central
nervous system, reproductive, and endocrine damage (Willet
et al., 1998). Its endocrine disruptor ability has been shown in
vitro (Steinmetz et al., 1996), but there have been few studies
on the thyroid-disrupting effects of b-HCH in human beings
(Mazhitova et al., 1998; Ribas-Fito et al., 2003; Alvarez-
Pedrerol et al., 2007a, 2008). In this study, a tendency to an
association between high prenatal b-HCH levels and greater
neonatal TSH levels was found, consistent with the ﬁndings
of earlier studies by the multi-center INMA project in other
Spanish areas (Ribas-Fito et al., 2003; Alvarez-Pedrerol
et al., 2008). A positive association between b-HCH in cord
serum and neonatal TSH levels was found in a cohort from
Northeastern Spain (Ribas-Fito et al., 2003), who showed
higher b-HCH levels (median¼ 0.5 ng/ml) than those
detected in this study (median¼ 0.08 ng/ml). In fact, the
babies in our series with umbilical cord serum b-HCH levels
490th percentile (median¼ 0.3 ng/ml) also showed a higher
neonatal TSH versus babies with lower prenatal exposure to
b-HCH (median¼ 0.02 ng/ml), similar to the above ﬁndings,
although the association did not reach signiﬁcance. A
relationship between cord serum b-HCH and postpartum
TSH levels was also recently reported in a cohort from the
Mediterranean island of Menorca (Alvarez-Pedrerol et al.,
2008), in which babies with TSHX10mIU/l showed similar
b-HCH levels (GM¼ 0.5 ng/ml) to the infants in this study
with higher exposure to this compound (GM¼ 0.4 ng/ml).
Finally, the Menorcan study found that serum b-HCH levels
(GM¼ 0.2 ng/ml) in preschoolers (4 years) were associated
with lower total triiodothyronine (TT3), but not with higher
TSH or free thyroxine (FT4) levels (Alvarez-Pedrerol et al.,
2007a). Other than these reports, few data have been
published on prenatal b-HCH exposure and thyroid
hormone status, and they showed no association between
b-HCH concentrations and thyroid hormone levels (Mazhi-
tova et al., 1998). With regard to b-HCH umbilical cord
levels, our results (median: 0.08 ng/ml or 34 ng/g) are lower
than levels found by Torres-Arreola et al. (2003) in Mexico
(54.25 ng/g) and Ataniyazova et al. (2001) in Uzbekistan
(2060 ng/l), and higher (3.38 ng/g) than levels found in China
(Tan et al., 2009).
We found no association between PCB levels in umbilical
cord serum and newborn TSH levels, in common with earlier
studies (Fiolet et al., 1997; Ribas-Fito et al., 2003; Otake
et al., 2007; Dallaire et al., 2008), but unlike some other
reports (Koopman-Esseboom et al., 1994; Chevrier et al.,
Table 3. Residues of OCs (ng/g lipid) in umbilical cord serum and
neonatal TSH (mIU/l) levels (n¼ 453), INMA-Valencia cohort,
2004–2006.
Residues XLOD GM 95% CI P50th P90th
4,40-DDTa 55.1 8.0 7.0, 9.3 8.4 61
4,40-DDEa 99.8 197 181, 213 187 551
HCBa 92.5 75 68, 82 87 225
b-HCHa 78.4 20 17, 23 34 104
PCB 118a 71.5 19 18, 21 23 68
PCB 138a 86.1 29 26, 31 34 69
PCB 153a 95.1 40 37, 43 46 87
PCB 180a 91.8 27 25, 30 33 61
SPCBsa F 131 123, 139 144 266
TSHb 100 1.3 1.2, 1.4 1.4 3.2
4,40-DDE, 1,1-dichloro-2,2-bis(4-chlorophenyl)ethylene; 4,40-DDT, 1,1,1-
trichloro-2,2-bis(4-chlorophenyl)ethane; b-HCH, beta-hexachlorocyclo-
hexane; CI, conﬁdence interval; GM, geometric mean; HCB, hexachlor-
obenzene; LOD, limit of detection; OC, organochlorine compounds;
P, percentile; PCBs, polychlorobiphenyls; SPCBs, sum of four PCBs (PCB
118, 138, 153, 180); TSH, thyroid stimulating hormone.
aExpressed on a lipid basis (ng/g lipid).
bExpressed in mIU/l.
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Table 4. Unadjusted and adjusted regression analyses between OC concentrations in umbilical cord serum and neonatal TSH levels (n¼ 453),
INMA-Valencia cohort, 2004–2006.
Residues TSH
Unadjusted regression analyses Adjusted regression analysesa
% changeb 95% CI P % changeb 95% CI P
4,40-DDT 0.6c 9.7, 9.3 0.89 0.7c 9.6, 9.2 0.89
oP50th Rd Rd
P50th–P90th 0.2d 12.6, 14.9 0.97 0.9d 13.4, 13.5 0.90
4P90th 1.0d 20.7, 23.5 0.93 1.9d 21.3, 22.3 0.86
4,40-DDE 2.8 17.9, 15.1 0.74 1.0 16.7, 17.7 0.91
oP50th R R
P50th–P90th 5.2 8.2, 20.6 0.46 5.4 8.0, 20.8 0.45
4P90th 5.1 23.9, 18.4 0.64 5.2 24.4, 18.9 0.64
HCB 1.5 12.2, 17.3 0.84 2.8 16.4, 13.1 0.72
oP50th R R
P50th–P90th 6.6 7.0, 22.2 0.36 4.9 8.9, 20.7 0.51
4P90th 9.5 12.2, 36.6 0.42 6.6 15.0, 33.7 0.58
b-HCH 2.0 7.3, 12.2 0.69 1.4 8.1, 11.8 0.79
oP50th R R
P50th–P90th 3.5 15.8, 10.6 0.61 4.2 16.6, 10.1 0.55
4P90th 21.8 2.3, 51.8 0.08* 21.0 3.0, 50.8 0.09*
PCB 118 0.3 13.6, 16.6 0.96 2.1 15.7, 13.8 0.78
oP50th R R
P50th–P90th 2.6 15.0, 11.7 0.71 3.7 16.0, 10.4 0.59
4P90th 3.6 22.6, 20.0 0.74 5.5 24.0, 17.4 0.61
PCB 138 7.8 9.6, 28.6 0.40 5.3 12.2, 26.3 0.58
oP50th R R
P50th–P90th 4.8 8.5, 20.2 0.50 3.6 9.9, 19.2 0.62
4P90th 0.9 19.1, 25.9 0.94 0.9 19.3, 26.1 0.94
PCB 153 3.4 20.3, 17.1 0.73 11.1 27.8, 9.5 0.27
oP50th R R
P50th–P90th 9.8 4.2, 25.9 0.18 7.1 7.1, 23.5 0.35
4P90th 8.3 26.3, 14.1 0.44 11.8 29.8, 10.7 0.28
PCB 180 3.8 19.3, 14.8 0.67 12.2 27.5, 6.4 0.19
oP50th R R
P50th–P90th 7.0 6.6, 22.7 0.33 4.4 9.4, 20.4 0.55
4P90th 2.4 21.6, 21.6 0.83 5.4 24.7, 19.0 0.64
SPCBs 1.5 19.1, 27.3 0.90 5.3 25.4, 20.2 0.65
oP50th R R
P50th–P90th 10.5 3.6, 26.6 0.15 7.5 6.4, 23.5 0.31
4P90th 4.3 16.4, 30.1 0.71 1.3 19.0, 26.8 0.91
*Po0.10.
4,40-DDE, 1,1-dichloro-2,2-bis(4-chlorophenyl)ethylene; 4,40-DDT, 1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane; b-HCH, beta-hexachlorocyclohexane;
CI, conﬁdence interval; HCB, hexachlorobenzene; OC, organochlorine compounds; P, percentile; PCBs, polychlorobiphenyls; R, reference; SPCBs, sum of
PCB congeners 118, 138, 153, 180; TSH, thyroid stimulating hormone.
aAdjusted for maternal age, age at time of sampling, prematurity, small weight for gestational age, prenatal smoking at third trimester of pregnancy, and sex.
bPercentage of change in neonatal TSH levels (mIU/l) associated with a 10-fold increase in exposure or with a change from the reference to current category.
cRegression analyses with OC as continuous variables (log10 transformed).
dRegression analyses with OC as categorical variables (oP50, 50–90, 490).
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2007; Alvarez-Pedrerol et al., 2008). This discrepancy in
results may be explained by differences in PCB levels, in the
matrix used for exposure quantiﬁcation, in the speciﬁc
congeners selected for measurement, in the sample size, or
in the statistical analysis, including strategies to control for
other covariates.
We found no association among HCB, 4,40-DDT, or 4,40-
DDE and neonatal TSH, in agreement with earlier
investigations (Dewailly et al., 1993; Ribas-Fito et al.,
2003; Alvarez-Pedrerol et al., 2008). However, an associa-
tion was earlier reported in the present cohort between
maternal 4,40-DDE levels and maternal TSH levels at 12
weeks of pregnancy (Lopez-Espinosa et al., 2009).
Thyroid function has a crucial function in brain matura-
tion and development in human beings (Dussault and Ruel,
1987). Some studies on newborns with congenital hypothyr-
oidism found an association between thyroid hormone levels
at birth and impairment of neurodevelopment (Weber et al.,
2000). However, there is little information on the role of
thyroid function in brain development of infants whose
abnormality in neonatal thyroid function is transient or mild
(Rose et al., 2006). Nevertheless, some studies suggested that
subtle changes in thyroid hormone homeostasis may affect
the development of the central nervous system, as growth and
development in the fetus and during childhood is highly
dependent on normal levels of thyroid hormones (Dussault
and Ruel, 1987). One study of preschool children found that
TSH levels in the upper quartile of the normal range were
related to impairment of cognitive function and attention
behavior (Alvarez-Pedrerol et al., 2007b). Moreover, thyroid
hormone disruption has been proposed as a potential
mechanism of action for the neurodevelopment effects of
certain OCs (Porterﬁeld, 2000). We have traced only one
study that addressed this issue in relation to b-HCH; the
authors found an adverse association between prenatal
exposure to this compound and neonatal neurodevelopment,
suggesting that the ability of b-HCH to alter thyroid
hormones may be responsible for the action (Fenster et al.,
2007).
Our study has some limitations. One of them is the
participation rate (54%). A descending trend in participation
rates has been described, especially in relation to studies in
which biological specimens are collected (Morton et al.,
2006). Although low participation itself does not necessarily
compromise the internal validity of a study, these studies may
be more vulnerable to self-selection bias than those with a
high participation (Morton et al., 2006). However, an earlier
study of our cohort found no differences in age participants
and non-participants, although working was more frequent
among participants (Rodriguez et al., 2006). A further
limitation is that a complete dataset was not available for the
entire cohort (453 versus 787), which may introduce a
potential bias. This study found differences between study
participants and non-participants in area of residence, birth
weight, and earlier miscarriages. A relationship has been
reported between altered thyroid hormone levels and the risk
of low –birth weight (LaFranchi, 1999), and these repro-
ductive outcomes have also been associated with higher OC
exposure (Longnecker et al., 2001; Venners et al., 2005;
Halldorsson et al., 2008). Therefore, any selection bias
caused by the loss of these cases would be more likely
to underestimate the associations between OCs and
neonatal TSH. On the other hand, the TSH levels observed
did not differ from those measured in neonates of the cohort
who were not included in our study. Furthermore, a
descriptive study (Barona-Vilar et al., 2008) on congenital
hypothyroidism screening data from Valencia during the
period 2004–2006 also showed a distribution of TSH values
similar to that observed in our study (median¼ 1.23 versus
1.4mIU/l in this study), indicating that our study sample
might be representative of the general population in our area.
However, the fact that TSH levels were all within the normal
range precluded the possibility of assessing the association
between OC exposure and abnormal neonatal TSH values. A
further possible limitation is that we have data on
concentrations of TSH at birth, but not on concentrations
of total T3 (TT3), free T3 (FT3), TT4, or FT4. Finally,
subjects would have been simultaneously exposed to a huge
variety of chemicals that may have synergistic or cumulative
effects.
Study strengths are that trained interviewers prospectively
collected our data, and we considered all known important
covariates in our analysis. Moreover, we lost few participants
between recruitment and delivery. Our sample size was
also larger than in many studies on prenatal exposure to
OCs and thyroid hormone levels, allowing consideration of
the effect of a large number of covariates. Thus, the similar
effect estimates found in unadjusted and adjusted models
indicate that residual covariates had little effect on results.
Our ﬁndings were consistent with those of earlier Spanish
cohorts in which OC levels were measured in the same
laboratory and neonatal TSH levels were assessed using
the same technique (part of routine early screening for
hypothyroidism in Spanish hospitals), supporting the validity
of this study.
In conclusion, although cord blood levels of most of the
studied OCs were not associated with TSH at birth in our
sample, our results suggest that prenatal exposure to high
levels of b-HCH may alter thyroid status, as earlier reported.
This study, therefore, contributes to our understanding of the
limited available data on the association between thyroid
hormone levels and prenatal OC exposure. This investigation
forms part of a cohort study in which thyroid hormone and
OC levels have been measured at different stages of
pregnancy in the mother and at birth and will be followed
in the children during their later life. This approach will allow
us to determine possible associations between prenatal OC
exposure and thyroid hormone levels at different time
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windows of exposure and to evaluate their impact on the
neurodevelopment of these children.
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